Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancer.
Wang JH, Deek MP, Mendes AA, Song Y, Shetty A, Bazyar S, Van der Eecken K, Chen E, Showalter TN, Royce TJ, Todorovic T, Huang HC, Houck SA, Yamashita R, Kiess AP, Song DY, Lotan T, DeWeese T, Marchionni L, Ren L, Sawant A, Simone N, Berlin A, Onal C, Esteva A, Feng FY, Tran PT, Sutera P, Ost P.
Wang JH, et al. Among authors: todorovic t.
Radiother Oncol. 2025 Jan;202:110618. doi: 10.1016/j.radonc.2024.110618. Epub 2024 Nov 6.
Radiother Oncol. 2025.
PMID: 39510141
Free article.